Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Judson

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Cancer Chemotherapy and Pharmacology|September 3, 2018
Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer modelsUdai Banerji, Nivedita Sain, Swee Y Sharp, et al.
Cancer|October 28, 2008
Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapyAlex D Drilon, Sanjay Popat, Gauri Bhuchar, et al.
Sarcoma|April 11, 2022
Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) DatabaseGeorgios Kantidakis, Saskia Litière, Hans Gelderblom, et al.
Pediatric Blood & Cancer|April 21, 2015
Primary cutaneous and subcutaneous Ewing sarcomaAngela Di Giannatale, Anna Maria Frezza, Marie-Cécile Le Deley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic dataChiaki Tanaka, Terence O'Reilly, John M Kovarik, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2010
A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: unplanned admissions as an early indicator of patient attritionAndre T Brunetto, Joo Ern Ang, David Olmos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancersRuth Plummer, Gerhardt Attard, Simon Pacey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignanciesUdai Banerji, Anne O'Donnell, Michelle Scurr, et al.
Lancet (London, England)|September 29, 2004
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialJaap Verweij, Paolo G Casali, John Zalcberg, et al.
Clinical Sarcoma Research|April 24, 2015
Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access programAttila Kollàr, Marco Maruzzo, Christina Messiou, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Cancer Chemotherapy and Pharmacology|September 3, 2018
Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer modelsUdai Banerji, Nivedita Sain, Swee Y Sharp, et al.
Cancer|October 28, 2008
Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapyAlex D Drilon, Sanjay Popat, Gauri Bhuchar, et al.
Sarcoma|April 11, 2022
Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) DatabaseGeorgios Kantidakis, Saskia Litière, Hans Gelderblom, et al.
Pediatric Blood & Cancer|April 21, 2015
Primary cutaneous and subcutaneous Ewing sarcomaAngela Di Giannatale, Anna Maria Frezza, Marie-Cécile Le Deley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic dataChiaki Tanaka, Terence O'Reilly, John M Kovarik, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2010
A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: unplanned admissions as an early indicator of patient attritionAndre T Brunetto, Joo Ern Ang, David Olmos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancersRuth Plummer, Gerhardt Attard, Simon Pacey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignanciesUdai Banerji, Anne O'Donnell, Michelle Scurr, et al.
Lancet (London, England)|September 29, 2004
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialJaap Verweij, Paolo G Casali, John Zalcberg, et al.
Clinical Sarcoma Research|April 24, 2015
Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access programAttila Kollàr, Marco Maruzzo, Christina Messiou, et al.
Pageof 16